To promote YUVEZZI, a prescription eye drop for treating presbyopia, through a national direct-to-consumer campaign, as reported by Business Wire.
Approach:
Campaign Theme: The campaign, titled Friends of the Presbyopians, uses hand-crafted puppets to illustrate frustrations related to blurry close-up vision.
Media Channels: The campaign is launching nationwide across digital and social channels.
Key Findings:
YUVEZZI is a dual-agent ophthalmic solution containing carbachol and brimonidine tartrate.
It is approved for adults with age-related blurry near vision.
Presbyopia affects about 128 million adults in the US and approximately 2 billion people globally.
YUVEZZI provided up to eight continuous hours of improved close-up vision in medical studies.
Common side effects include headache, impaired vision, and temporary eye pain or irritation.
Interpretation:
The campaign aims to raise awareness about presbyopia and encourage discussions with eye care professionals.
Conclusion:
The campaign represents a strategic effort by Tenpoint Therapeutics to build market momentum for YUVEZZI, according to Henric Bjarke, CEO of Tenpoint Therapeutics.
